The series B fundraising will support the clinical development of next-generation multivalent vaccines against respiratory ...

UCB and Biogen revealed that their Phase 3 study testing dapirolizumab pegol in people with systemic lupus erythematosus met ...

Although vaccines already exist to prevent mpox, high prices and the risk of side effects make it difficult to roll them out ...

Dandelion Health used its new clinical AI marketplace to analyze real-world data, showing that GLP-1 drugs may help prevent ...

The new company focuses on producing components needed to manufacture RNA-based therapies for which there is increasing ...

Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.

MinervaX and Wacker Biotech announced yesterday that they have entered into a manufacturing agreement for MinervaX’s ...

The FDA has granted Orphan Drug and Rare Pediatric Disease Designations to Somite’s cell replacement therapy for the ...

Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...

The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...

With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...